BRÈVE

sur Yunu

Yunu Introduces Advanced Imaging Workflow for Investigator-Initiated Trials

Yunu has announced the expansion of its clinical trial imaging, reading, and data management platform, specifically tailored for investigator-initiated trials (IITs). This technology enables Principal Investigators (PIs) to quickly set up trial sites, expand trials to diverse communities, and manage data in real-time via a comprehensive cloud-based platform.

The platform addresses common challenges in multi-site IITs, such as logistical issues, communication barriers, and administrative complexities, by offering a unified system that supports seamless collaboration and coordination of research. Yunu's platform is already utilized in over 20% of NCI-designated Comprehensive Cancer Centers, indicating significant adoption within the industry.

Gordon Harris, Chief Science Officer and co-founder of Yunu, emphasized the platform’s role in transforming clinical trials by providing a connected, efficient and technology-driven workflow. This innovation not only accelerates the process of translating scientific discoveries to real-world applications but also makes trials more accessible and easier to manage across multiple sites.

R. P.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Yunu